Postdoctoral Fellow In Cancer Immunology And Nanomedicine
Listed on 2025-12-21
-
Research/Development
Research Scientist, Immunology Research
Postdoctoral Fellow In Cancer Immunology And Nanomedicine
This is a full-time, on-site role for a Postdoctoral Fellow in Cancer Immunology and Nanomedicine in the Tadepalli Lab based in Indianapolis, IN. The Tadepalli Lab investigates how myeloid cells regulate immune outcomes during cancer therapy.
By integrating molecular engineering with cancer immunology, we design nano-enabled therapeutics that modulate immune signaling and enhance crosstalk between myeloid and lymphoid cells. Our interdisciplinary research program spans immunology, nanotechnology, materials science, and molecular engineering, bringing together tools such as flow cytometry, animal models, and bio/nanomaterial synthesis.
Responsibilities- Design and execute in vivo tumor and radiation experiments in murine models.
- Perform high-dimensional immunophenotyping, transcriptomics, mouse colony management, and molecular biology assays.
- Collaborate on nanomaterial synthesis and functionalization for targeted immune modulation.
- Perform mechanistic assays to define immune activation and signaling pathways.
- Prepare figures, manuscripts, and contribute to grant development.
- PhD in Immunology, Cancer Biology, Biomedical Engineering, or a related discipline.
- Demonstrated experience in mouse handling and tumor models or nanomedicine/biomedical engineering.
- Strong experimental design skills and a record of research productivity.
- Excellent written and verbal communication abilities.
IUSMis is committed to being a welcoming campus community and we seek candidates whose research, teaching, and community engagement efforts contribute to robust learning and working environments for all students, staff, and faculty. We invite individuals who will join us in our mission to improve health equity and well-being for all throughout the state of Indiana.
#J-18808-Ljbffr(If this job is in fact in your jurisdiction, then you may be using a Proxy or VPN to access this site, and to progress further, you should change your connectivity to another mobile device or PC).